Over 39 million Americans live with migraine, and the majority of them can reduce both attack frequency and severity — when the treatment matches the mechanism. This is the storm map: what happens in each phase, how aura works, how triptans interrupt an attack, which triggers actually matter, and which symptoms mean something else entirely.
What patients call "a migraine" is usually one phase of a longer neurological event. The headache is the loudest symptom, but the cycle begins hours or days before it and lingers after it ends.
The mechanism involves activation of the trigeminal nerve and the release of neuropeptides — most notably calcitonin gene-related peptide (CGRP) — which dilate cranial blood vessels, sensitize nerve endings, and sustain the pain. The old theory that migraine was primarily a vascular problem has been replaced by a neurovascular model in which the nervous system drives the vascular changes, not the other way around.
This is why the newest migraine drugs — CGRP monoclonal antibodies and gepants — target the neuropeptide itself rather than the blood vessels, and why they work as both acute and preventive treatment. It is also why migraine is classified as a neurological disorder, not a symptom.
Subtle warning signs: yawning, food cravings, irritability, neck stiffness, difficulty concentrating, sensitivity to light. Recognizing this phase lets you treat early.
Present in about 25% of patients. Most commonly visual — flashing lights, zigzag lines, blind spots. Can also be sensory (tingling) or, rarely, involve speech. Usually resolves before the headache begins.
Moderate to severe throbbing pain, often one-sided, worsening with routine activity. Frequently accompanied by nausea, vomiting, and sensitivity to light and sound. This is when acute treatment is most effective.
The "migraine hangover." Fatigue, difficulty concentrating, mood changes, and lingering sensitivity to stimuli. Many patients feel drained for a full day after the pain resolves.
A typical visual aura begins near the center of vision and gradually expands outward over 5 to 20 minutes. The classic shape is a fortification spectrum — a jagged line of shimmering, colored light that resembles a medieval fortress wall.
Behind the expanding zigzag is usually a scotoma — a blind spot that patients describe as "not being able to see through" the affected area, even though they may not consciously notice it until tested.
Aura is not the same as a seizure, and it is not the same as a stroke. It usually resolves within 60 minutes. Any aura lasting longer than an hour, or any new focal neurological symptom after age 50, requires urgent evaluation.
Triptans are not painkillers. They activate 5-HT1B/1D serotonin receptors, which constrict dilated cranial vessels and reduce the release of CGRP and other pain-signaling peptides. Taken early in the attack, they abort or substantially reduce symptoms in most patients.
| Triptan | Onset | Half-life | Notes |
|---|---|---|---|
| Sumatriptan | ~30 min | ~2 hrs | Most studied. Available as tablets, nasal spray, and injection. Generic available. |
| Rizatriptan | ~30 min | ~2–3 hrs | Fast onset. Available as orally disintegrating tablets. Generic available. |
| Eletriptan | ~30–60 min | ~4 hrs | Higher efficacy in some comparative studies. Not for use within 72 hrs of certain CYP3A4 inhibitors. |
| Almotriptan | ~30–60 min | ~3–4 hrs | Fewer drug interactions. Well tolerated in many patients. |
| Naratriptan | ~60 min | ~6 hrs | Slower onset but longer duration. Useful for prolonged attacks. |
| Frovatriptan | ~120 min | ~26 hrs | Very long half-life. Often used for menstrual migraine prevention. |
Two newer classes have entered the U.S. market in recent years. Gepants — ubrogepant and rimegepant — are oral CGRP receptor antagonists taken at the onset of an attack. They are slower than triptans but do not constrict blood vessels, which makes them a reasonable option for patients with cardiovascular risk factors who cannot safely take a triptan. Ditans — lasmiditan — are 5-HT1F agonists that also avoid vasoconstriction, but carry a warning about driving impairment.
The most common reason a triptan "does not work" is not that it is the wrong triptan. It is taking it too late. Triptans are most effective when taken early in the headache phase — ideally within 20 to 30 minutes of the pain beginning, and often at the first sign of the prodrome if the patient recognizes it. Waiting until the pain is severe substantially reduces the response rate.
Two practical rules matter as much as the choice of drug. First, triptans are contraindicated in patients with coronary artery disease, uncontrolled hypertension, prior stroke, or certain types of hemiplegic or basilar migraine. Second, using acute medication on more than 10 days per month can cause medication overuse headache — a chronic daily headache that paradoxically worsens the original condition.
Taking acute migraine medication on 10 or more days per month (for triptans and combination analgesics) or 15 or more days per month (for simple analgesics) can lead to chronic daily headache. This is one of the most common reasons for a worsening migraine pattern — and it usually requires a managed withdrawal, not more medication.
Triggers are personal, but the categories are consistent. Some matter far more than others, and a few are more myth than mechanism.
Both too little and too much sleep are common triggers. Irregular schedules are worse than short sleep alone. Consistent wake times matter more than total hours.
Stress itself is a trigger, but the relaxation after stress — the weekend, the vacation, the day after a deadline — is often when the attack actually begins. This is why "weekend migraine" is a recognized pattern.
Estrogen withdrawal around menstruation triggers attacks in many women. Menstrual migraine is often more prolonged and less responsive to acute treatment than attacks at other times of the cycle.
Shifts in atmospheric pressure, high humidity, and temperature swings correlate with migraine in some patients. Unlike other triggers, weather cannot be avoided — so it is used more as a forecasting tool than a control lever.
Alcohol (especially red wine), aged cheese, processed meats, and aspartame are often cited. Skipping meals is a more reliable trigger than any specific food for most patients.
Bright light, flickering screens, strong perfumes, and loud environments trigger attacks in sensitive patients. Photophobia between attacks is itself a marker of migraine biology — not a personality trait.
Most headaches in patients with a migraine diagnosis are migraine. The following features, however, are treated as secondary headaches until proven otherwise — and require prompt evaluation.
The price landscape in migraine treatment is genuinely uneven. Triptans are available as generics — sumatriptan, rizatriptan, naratriptan, and almotriptan all have low-cost generic versions in the United States, and sumatriptan in particular is widely stocked at a fraction of its original brand price. Older preventives — propranolol, amitriptyline, topiramate — are also inexpensive generics.
Where costs climb sharply is with the newer agents: CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab), gepants (ubrogepant, rimegepant), and botulinum toxin for chronic migraine. These can run into the hundreds or thousands of dollars per month without insurance, and coverage varies widely by plan. Many manufacturers run patient assistance and copay programs that bring the cost down substantially for commercially insured patients.
Regardless of which drug is prescribed, the same comparison logic applies: the price varies by more than five-fold between licensed U.S. pharmacies for the same tablet. A live prescription price comparison shows the current spread in about two minutes, and the same approach works for every generic on the list. If you are starting an online refill for the first time, the process is documented step by step in this how to order prescriptions online guide — prescription first, licensed seller second, small first order third.
One practical warning specific to migraine: do not skip preventive doses to save money, and do not stockpile acute medication to extend a prescription. Both are common responses to cost pressure, and both make the underlying condition worse. If the medication is unaffordable, tell the prescriber — there is almost always a cheaper alternative, a manufacturer assistance program, or a different drug class that fits the budget.
Before you sign for any seller, verify them. A working VIPPS seal that resolves to a live NABP record, a real U.S. street address, and a prescription requirement that cannot be waived. A transparency page like this one about Metformin4You is a reasonable example of the standard to expect.
Triptans and many preventives are available as low-cost generics, and the same tablet can cost five to ten times more at one licensed pharmacy than another. A two-minute comparison across licensed U.S. sellers is the highest-yield habit you can add to a migraine treatment plan — no prescription change required. Begin with the current Metformin price comparison as a live demonstration of how wide the spread runs.
Open the price comparison